QIAGEN to Advance AI-Driven Drug Discovery with Graph-Based AI and ...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
QIAGEN announced that its bioinformatics division, QIAGEN Digital Insights, with its curated knowledge databases and bioinformatics expertise, will integrate NVIDIA Accelerated Computing and the NVIDIA BioNeMo platform to help researchers use AI more effectively in drug discovery.
QIAGEN Partners with NVIDIA to Integrate Graph-Based AI for Drug Discovery
QIAGEN will advance AI-driven drug discovery by incorpo […] The post QIAGEN Partners with NVIDIA to Integrate Graph-Based AI for Drug Discovery first appeared on GeneOnline News. The post QIAGEN Partners with NVIDIA to Integrate Graph-Based AI for Drug Discovery appeared first on GeneOnline News.
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases The post QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA first appeared on Medical Device News Magazine.
QIAGEN to advance AI-driven drug discovery with graph-based AI and ...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
